DK160078C - Farmaceutisk praeparat til behandling af stofskiftesygdomme og fremgangsmaade til dets fremstilling - Google Patents

Farmaceutisk praeparat til behandling af stofskiftesygdomme og fremgangsmaade til dets fremstilling

Info

Publication number: DK160078C
Authority: DK; Denmark
Prior art keywords: preparation; gonadoliberin; treatment; single dose; procedure
Prior art date: 1983-09-08

Application number

DK429784A

Other languages

Danish (da)

English (en)

Other versions

DK160078B (da

DK429784D0 (da

DK429784A (da

Inventor

Wolfgang Koenig

Horst Neubauer

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-09-08

Filing date

1984-09-07

Publication date

1991-06-24

1984-09-07 Application filed by Hoechst Ag filed Critical Hoechst Ag

1984-09-07 Publication of DK429784D0 publication Critical patent/DK429784D0/da

1985-03-09 Publication of DK429784A publication Critical patent/DK429784A/da

1991-01-28 Publication of DK160078B publication Critical patent/DK160078B/da

1991-06-24 Application granted granted Critical

1991-06-24 Publication of DK160078C publication Critical patent/DK160078C/da

Links

238000000034 method Methods 0.000 title abstract 2
201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
230000003340 mental effect Effects 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
102000009165 Gonadoliberin Human genes 0.000 abstract 5
108050000048 Gonadoliberin Proteins 0.000 abstract 5
102000003982 Parathyroid hormone Human genes 0.000 abstract 2
108090000445 Parathyroid hormone Proteins 0.000 abstract 2
239000000556 agonist Substances 0.000 abstract 2
208000030159 metabolic disease Diseases 0.000 abstract 2
239000000199 parathyroid hormone Substances 0.000 abstract 2
229960001319 parathyroid hormone Drugs 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 2
230000028327 secretion Effects 0.000 abstract 2
238000009472 formulation Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
238000007911 parenteral administration Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Neurology (AREA)
Heart & Thoracic Surgery (AREA)
Emergency Medicine (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Reproductive Health (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Cardiology (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK429784A 1983-09-08 1984-09-07 Farmaceutisk praeparat til behandling af stofskiftesygdomme og fremgangsmaade til dets fremstilling DK160078C (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19833332329 DE3332329A1 (de)	1983-09-08	1983-09-08	Verwendung von gonadoliberin und gonadoliberinagonisten zur behandlung von stoffwechselerkrankungen, die auf zu geringe parathormonspiegel zurueckzufuehren sind
DE3332329		1983-09-08

Publications (4)

Publication Number	Publication Date
DK429784D0 DK429784D0 (da)	1984-09-07
DK429784A DK429784A (da)	1985-03-09
DK160078B DK160078B (da)	1991-01-28
DK160078C true DK160078C (da)	1991-06-24

Family

ID=6208498

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK429784A DK160078C (da)	1983-09-08	1984-09-07	Farmaceutisk praeparat til behandling af stofskiftesygdomme og fremgangsmaade til dets fremstilling

Country Status (8)

Country	Link
EP (1)	EP0137294B1 (fr)
JP (1)	JPS6072824A (fr)
AT (1)	ATE42467T1 (fr)
AU (1)	AU567183B2 (fr)
DE (2)	DE3332329A1 (fr)
DK (1)	DK160078C (fr)
GR (1)	GR80312B (fr)
ZA (1)	ZA847047B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3414595A1 (de) *	1984-04-18	1985-10-31	Hoechst Ag, 6230 Frankfurt	Verwendung von gonadoliberin und gonadoliberinagonisten zur behandlung klimakterischer beschwerden
FR2623912B1 (fr) *	1987-11-27	1990-03-23	Lacroix E Tous Artifices	Detecteur radioaltimetrique et fusee de proximite equipee d'un tel detecteur

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2450109B1 (fr) *	1977-11-08	1986-03-28	Roussel Uclaf	Nouvelle methode de traitement utilisant la lh-rh, ou des agonistes
FR2465486A1 (fr) *	1979-09-21	1981-03-27	Roussel Uclaf	Nouvelle application utilisant la lh-rh ou des agonistes

1983
- 1983-09-08 DE DE19833332329 patent/DE3332329A1/de not_active Withdrawn
1984
- 1984-09-03 AT AT84110442T patent/ATE42467T1/de not_active IP Right Cessation
- 1984-09-03 DE DE8484110442T patent/DE3477882D1/de not_active Expired
- 1984-09-03 EP EP84110442A patent/EP0137294B1/fr not_active Expired
- 1984-09-07 JP JP59186621A patent/JPS6072824A/ja active Pending
- 1984-09-07 GR GR80312A patent/GR80312B/el unknown
- 1984-09-07 AU AU32839/84A patent/AU567183B2/en not_active Ceased
- 1984-09-07 ZA ZA847047A patent/ZA847047B/xx unknown
- 1984-09-07 DK DK429784A patent/DK160078C/da active

Also Published As

Publication number	Publication date
ZA847047B (en)	1985-04-24
DE3477882D1 (en)	1989-06-01
GR80312B (en)	1985-01-02
EP0137294B1 (fr)	1989-04-26
DK160078B (da)	1991-01-28
DK429784D0 (da)	1984-09-07
EP0137294A2 (fr)	1985-04-17
DK429784A (da)	1985-03-09
AU567183B2 (en)	1987-11-12
DE3332329A1 (de)	1985-03-28
ATE42467T1 (de)	1989-05-15
EP0137294A3 (en)	1987-04-15
JPS6072824A (ja)	1985-04-24
AU3283984A (en)	1985-03-14

Similar Documents

Publication	Publication Date	Title
IL83363A (en)	1993-07-08	Use of indol-3-yl-carboxylic acid endo-8-methyl-8-aza- bicyclo (3,2,1) oct-3-yl ester for the preparation of psycho-active pharmaceutical compositions suitable for the treatment of stress- related psychiatric disorders or for increasing vigilance
GR880300058T1 (en)	1988-10-18	Pharmaceutical compositions containing levodopa methyl ester, preparation and therapeutic applications thereof
AU588202B2 (en)	1989-09-07	Dosage form for delivering acid sensitive beneficial agent
EP0508488A3 (fr)	1992-10-28	Utilisation de l'inositol-triphosphate pour le traitement des maladies associées aux intoxications par des métaux
IL99699A0 (en)	1992-08-18	Method of treating or preventing type 1 diabetes by oral administration of insulin
ES2036199T3 (es)	1993-05-16	Procedimiento de obtencion de un preparado farmaceutico administrable a traves de una membrana corporal.
AU1578688A (en)	1988-11-04	Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines
PT615754E (pt)	2002-11-29	Formas solidas de administracao oral de libertacao controlada flupertina
ZA835237B (en)	1984-03-28	New derivatives of 2-azabicyclo(2.2.2)octane-3-carboxylic acid,a process for their preparation,agents containing these derivatives and the use thereof,and of 2-azabicyclo(2.2.2)octane-3-carboxylic acid,as an intermediate stage and a process for the preparation thereof
IL91949A (en)	1993-08-18	Dispersible formulation containing the free acid form of diclofenac
WO1987004926A3 (fr)	1988-05-19	Procede permettant de modifier la structure lipidique des membranes cellulaires et compositions pharmaceutiques utilisees a cet effet
GR3025792T3 (en)	1998-03-31	Use of phosphonates for the treatment of osteoporosis.
ZA892877B (en)	1989-12-27	Azelastine-containing medicaments with controlled release of the active substance
SE415367B (sv)	1980-09-29	Forfarande for limning med resorcinolhartslim med anvendning av en uppslamning av paraformaldehyd som herdare samt herdarkomposition for anvendning vid settet
ZA87216B (en)	1987-08-26	A pharmaceutical composition with sustained release of the active component and a process for the preparation thereof
DK160078C (da)	1991-06-24	Farmaceutisk praeparat til behandling af stofskiftesygdomme og fremgangsmaade til dets fremstilling
AU2908389A (en)	1989-07-19	Device for administering medicaments by atomization in intubated or tracheotomized patients
ES8308317A1 (es)	1983-08-16	Procedimiento de preparacion de nuevos derivados de 2-fenilmorfolina.
GR3007347T3 (fr)	1993-07-30
NO172491C (no)	1993-07-28	Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
EP0351876A3 (fr)	1990-04-18	Composition pour augmenter l'effet de vaccination
JPS55122715A (en)	1980-09-20	Antidiabetic agent
JPS5793913A (en)	1982-06-11	Enhancing agent for spermous vital power
DE3568944D1 (en)	1989-04-27	Pharmaceutical composition for oral administration containing, on the one hand, as active principle the 9-alpha,11-beta dichloro-16-alpha methyl 21-oxycarbonyldicyclohexylmethyloxy pregna-1,4-diene 3,20-dione and, on the other hand, an inert pharmaceutical excipient which is able to permit the activity of the product in the rectum or in the colon and the utilization of the active principle in the preparation of such a pharmaceutical composition
JPS5626819A (en)	1981-03-16	Preventive for hypoimmunity